Belén
Alfonso Bartolozzi
Forscherin bis um 2017
Harvard Medical School
Boston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Harvard Medical School (1)
2013
-
Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization
Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 1, pp. 537-544